Nonradiation-to-endoscopist Endoscopic Retrograde Cholangiopancreatography in Patients With Complexity Level I/II
NCT ID: NCT02697149
Last Updated: 2016-07-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
219 participants
OBSERVATIONAL
2015-12-31
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gut Microbiome in Biliary Atresia
NCT04260503
L-Gastrectomy With the Intelligent Navigation 4K UHD 3D Endoscopic Imaging System
NCT04526483
Staging LaParoscopy to Assess Lymph NOde InvoLvement in Advanced GAstric Cancer
NCT05720598
Endoscopic Submucosal Dissection Combine With Laparoscopic Regional Lymph Node Dissection for Early Gastric Cancer
NCT02325999
Clinical Evaluation of Narrow Band Imaging Colonoscope
NCT00628147
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intervention
patients undergoing nonradiation-to-endoscopist endoscopic retrograde cholangiopancreatography
nonradiation-to-endoscopist endoscopic retrograde cholangiopancreatography
All patients received magnetic resonance cholangiopancreatography before the procedure. Characteristics of lesions (e.g. common bile duct stones, stenosis) in detail was identified. During the procedure, the endoscopist was not exposed to radiation. If fluoroscopy was needed, after contrast injection (sometimes not necessary), the endoscopist went outside of the operation room and observed the X-ray image by remote control of the fluoroscopy machine.
control
patients undergoing standard endoscopic retrograde cholangiopancreatography
standard endoscopic retrograde cholangiopancreatography
Patients received standard endoscopic retrograde cholangiopancreatography. Fluoroscopy was normally used when necessary.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
nonradiation-to-endoscopist endoscopic retrograde cholangiopancreatography
All patients received magnetic resonance cholangiopancreatography before the procedure. Characteristics of lesions (e.g. common bile duct stones, stenosis) in detail was identified. During the procedure, the endoscopist was not exposed to radiation. If fluoroscopy was needed, after contrast injection (sometimes not necessary), the endoscopist went outside of the operation room and observed the X-ray image by remote control of the fluoroscopy machine.
standard endoscopic retrograde cholangiopancreatography
Patients received standard endoscopic retrograde cholangiopancreatography. Fluoroscopy was normally used when necessary.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients undergoing endoscopic retrograde cholangiopancreatography
Exclusion Criteria
* 2 common bile duct stone \> 15mm
* 3 common bile duct stone and distal stenosis
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Air Force Military Medical University, China
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yanglin Pan
Associated professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yanglin Pan, M.D.
Role: PRINCIPAL_INVESTIGATOR
Air Force Military Medical University, China
Wei Zeng, M.D.
Role: PRINCIPAL_INVESTIGATOR
Department of gastroenterology, Chinese PLA 174 hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of gastroenterology, Chinese PLA 174 Hospital
Xiamen, Fujian, China
Xijing Hospital of Digestive Diseases
Xi'an, Shaanxi, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Uradomo LT, Goldberg EM, Darwin PE. Time-limited fluoroscopy to reduce radiation exposure during ERCP: a prospective randomized trial. Gastrointest Endosc. 2007 Jul;66(1):84-9. doi: 10.1016/j.gie.2006.10.055.
Liao C, Thosani N, Kothari S, Friedland S, Chen A, Banerjee S. Radiation exposure to patients during ERCP is significantly higher with low-volume endoscopists. Gastrointest Endosc. 2015 Feb;81(2):391-8.e1. doi: 10.1016/j.gie.2014.08.001. Epub 2014 Oct 5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20151203-5
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.